3.0.0 2936 2023-01-15T06:02:46Z 2023-01-15T06:02:46Z House H HR 2003-07-25 108 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2003-08-08T14:39:30Z Referred to 2003-07-25T13:03:30Z 2003-08-08 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2003-07-25 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2003-07-25 Introduced in House IntroReferral Intro-H 9 Library of Congress 2003-07-25 Introduced in House IntroReferral 1000 9 Library of Congress D000275 Rep. Deutsch, Peter [D-FL-20] PETER DEUTSCH D FL 20 N S000303 Rep. Shaw, E. Clay, Jr. [R-FL-22] E. SHAW R FL CLAY 22 2003-07-25 True Health Commerce Crime and Law Enforcement Drug adulteration Drugs Fines (Penalties) Fraud Labeling Sentences (Criminal procedure) Health 00 2003-07-25 Introduced in House 2004-02-11T15:16:11Z Prescription Drug Tampering Prevention Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act to provide for fines or imprisonment, or both, for an individual for knowingly violating certain provisions by selling or trading adulterated or misbranded prescription drugs. Punishes an individual also for buying or trading for a prescription drug while knowing or having reason to know that the drug was knowingly caused to be adulterated or misbranded. States that in either instance an individual shall be fined in accordance with Federal law relating to crimes and criminal procedure, imprisoned for any term of years or for life, or both.

Modifies provisions pertaining to criminal penalties for committing certain prohibited acts involving food, drugs, devices, or cosmetics. Makes a violation punishable by a fine in accordance with Federal law relating to crimes and criminal procedure, imprisonment for not more than one year, or both. (Current law prescribes a fine of up to $1,000 and/or imprisonment for not more than one year). Makes a second violation, or a violation committed with intent to defraud or mislead, punishable by a fine in accordance with Federal law, imprisonment for not more than three years, or both. (Current law prescribes a fine of up to $10,000 and/or imprisonment for not more than three years.) Makes a violation of provisions pertaining to prescription drug marketing punishable by a fine in accordance with Federal law, imprisonment for not more than ten years, or both. (Current law prescribes a fine of up to $250,000 and/or imprisonment for not more than ten years.)

]]> Prescription Drug Tampering Prevention Act of 2003 Display Title Prescription Drug Tampering Prevention Act of 2003 Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act with respect to the sale or trade of prescription drugs that were knowingly caused to be adulterated or misbranded, and for other purposes. Introduced in House IH Short Titles as Introduced Prescription Drug Tampering Prevention Act of 2003 Introduced in House 2003-07-25T04:00:00Z 2003-08-08 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.